FusionArc optimization: A hybrid volumetric modulated arc therapy (VMAT) and intensity modulated radiation therapy (IMRT) planning strategy

被引:21
|
作者
Matuszak, Martha M. [1 ]
Steers, Jennifer M. [1 ,2 ]
Long, Troy [3 ]
McShan, Daniel L. [1 ]
Fraass, Benedick A. [4 ]
Romeijn, H. Edwin [3 ]
Ten Haken, Randall K. [1 ]
机构
[1] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Nucl Engn & Radiol Sci, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA
[4] Cedars Sinai Med Ctr, Dept Radiat Oncol, Los Angeles, CA 90048 USA
关键词
FusionArc; hybridArc; hybrid; VMAT; IMRT; HELICAL TOMOTHERAPY; RAPIDARC; CANCER;
D O I
10.1118/1.4808153
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To introduce a hybrid volumetric modulated arc therapy/intensity modulated radiation therapy (VMAT/IMRT) optimization strategy called FusionArc that combines the delivery efficiency of single-arc VMAT with the potentially desirable intensity modulation possible with IMRT. Methods: A beamlet-based inverse planning system was enhanced to combine the advantages of VMAT and IMRT into one comprehensive technique. In the hybrid strategy, baseline single-arc VMAT plans are optimized and then the current cost function gradients with respect to the beamlets are used to define a metric for predicting which beam angles would benefit from further intensity modulation. Beams with the highest metric values (called the gradient factor) are converted from VMAT apertures to IMRT fluence, and the optimization proceeds with the mixed variable set until convergence or until additional beams are selected for conversion. One phantom and two clinical cases were used to validate the gradient factor and characterize the FusionArc strategy. Comparisons were made between standard IMRT, single-arc VMAT, and FusionArc plans with one to five IMRT/hybrid beams. Results: The gradient factor was found to be highly predictive of the VMAT angles that would benefit plan quality the most from beam modulation. Over the three cases studied, a FusionArc plan with three converted beams achieved superior dosimetric quality with reductions in final cost ranging from 26.4% to 48.1% compared to single-arc VMAT. Additionally, the three beam FusionArc plans required 22.4%-43.7% fewer MU/Gy than a seven beam IMRT plan. While the FusionArc plans with five converted beams offer larger reductions in final cost-32.9%-55.2% compared to single-arc VMAT-the decrease in MU/Gy compared to IMRT was noticeably smaller at 12.2%-18.5%, when compared to IMRT. Conclusions: A hybrid VMAT/IMRT strategy was implemented to find a high quality compromise between gantry-angle and intensity-based degrees of freedom. This optimization method will allow patients to be simultaneously planned for dosimetric quality and delivery efficiency without switching between delivery techniques. Example phantom and clinical cases suggest that the conversion of only three VMAT segments to modulated beams may result in a good combination of quality and efficiency. (C) 2013 American Association of Physicists in Medicine.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Coplanar versus noncoplanar intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) treatment planning for fronto-temporal high-grade glioma
    Panet-Raymond, Valerie
    Ansbacher, Will
    Zavgorodni, Sergei
    Bendorffe, Bill
    Nichol, Alan
    Truong, Pauline T.
    Beckham, Wayne
    Vlachaki, Maria
    [J]. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2012, 13 (04): : 44 - 53
  • [32] Optimization approaches to volumetric modulated arc therapy planning
    Unkelbach, Jan
    Bortfeld, Thomas
    Craft, David
    Alber, Markus
    Bangert, Mark
    Bokrantz, Rasmus
    Chen, Danny
    Li, Ruijiang
    Xing, Lei
    Men, Chunhua
    Nill, Simeon
    Papp, David
    Romeijn, Edwin
    Salari, Ehsan
    [J]. MEDICAL PHYSICS, 2015, 42 (03) : 1367 - 1377
  • [33] VOLUMETRIC MODULATED ARC THERAPY (VMAT) TREATMENT PLANNING FOR SUPERFICIAL TUMORS
    Zacarias, Albert S.
    Brown, Mellonie F.
    Mills, Michael D.
    [J]. MEDICAL DOSIMETRY, 2010, 35 (03) : 226 - 229
  • [34] VALIDATION OF A VOLUMETRIC MODULATED ARC THERAPY (VMAT) TREATMENT PLANNING APPROACH
    Perez-Rozos, A.
    Lobato Munoz, M.
    Jerez Sainz, I.
    Medina, J. A.
    Carrasco Rodriguez, J. L.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S196 - S197
  • [35] Comparative planning of volumetric modulated arc therapy versus intensity modulated radiation therapy and proton beam therapy in anal cancer
    Hansen, J.
    Wilken, E.
    Petersen, J.
    Serup-Hansen, E.
    Spindler, K. -L.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 62 - 62
  • [36] The Dosimetric Advantage of Stereotactic Hypofractionation Over Conventional Radiation for Postprostatectomy Patients: NTCP Modeling of Intensity Modulated Radiation Therapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) Treatment Plans
    Boothe, D.
    Chang, J.
    Desai, P.
    Nagar, H.
    Zhou, L.
    Smith, M.
    Nori, D.
    Chao, K.
    Wernicke, A.
    Parashar, B.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S735 - S735
  • [37] VMAT Radiation Therapy (VMAT), Versus Intensity Modulated Radiation Therapy (IMRT) for Small-Sized Breast
    Yeh, C.
    Lai, P. A.
    Liu, F. H.
    Lai, K. K.
    Lee, P. R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S705 - S705
  • [38] Ultrafast treatment plan optimization for volumetric modulated arc therapy (VMAT)
    Men, Chunhua
    Romeijn, H. Edwin
    Jia, Xun
    Jiang, Steve B.
    [J]. MEDICAL PHYSICS, 2010, 37 (11) : 5787 - 5791
  • [39] Impact of machines on plan quality: volumetric modulated arc therapy and intensity modulated radiation therapy
    Clemente, S.
    Cozzolino, M.
    Oliviero, C.
    Fiorentino, A.
    Chiumento, C.
    Fusco, V.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (02): : 141 - 146
  • [40] Impact of machines on plan quality: volumetric modulated arc therapy and intensity modulated radiation therapy
    S. Clemente
    M. Cozzolino
    C. Oliviero
    A. Fiorentino
    C. Chiumento
    V. Fusco
    [J]. Clinical and Translational Oncology, 2014, 16 : 141 - 146